The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases.
about
Development of acute myeloid leukemia in patients with untreated chronic lymphocytic leukemia.MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer.TP53 mutation does not confer a poor outcome in adult patients with acute lymphoblastic leukemia who are treated with frontline hyper-CVAD-based regimens.Clinical Assessment and Diagnosis of Germline Predisposition to Hematopoietic Malignancies: The University of Chicago Experience.Molecular predictors of post-transplant survival in acute myeloid leukemia.Chromothripsis in acute myeloid leukemia: Biological features and impact on survival.Full-length mutation search of the TP53 gene in acute myeloid leukemia has increased significance as a prognostic factor.Single-molecule DNA sequencing of acute myeloid leukemia and myelodysplastic syndromes with multiple TP53 alterations.ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.Chromothripsis in acute myeloid leukemia: biological features and impact on survival.Treating hematological malignancies with drugs inhibiting ribosome biogenesis: when and why.A new adult AML case with an extremely complex karyotype, remission and relapse combined with high hyperdiploidy of a normal chromosome set in secondary AML
P2860
Q30238679-34662179-7321-43A1-B5F5-AED34D84395AQ33869257-72FBEC6A-D921-4B05-9FC8-E03CE619BD53Q46317683-6F5D2A02-03A8-4124-9045-FCE4AD16C02FQ47128524-C9290622-B463-4BDD-95B6-1697B993780AQ47256283-313E9163-8E24-4F99-B94E-730ADA636C54Q47574634-6E270E17-3AC5-49AD-9DAD-AD1ED8988600Q48242145-8AA54C41-E1CD-4A53-86BE-C7AF3E5B43B3Q49165108-7374991D-3281-4DC1-BC75-38CE040B884FQ50146313-4E4619FC-9423-4C4B-AFA6-E89B94904825Q52374501-82BE5F5F-A302-4834-A171-AD268D497CCEQ54977441-5A1C92BE-746A-4C0D-BCAE-76DBBA41B63FQ56517348-F609D409-F929-407E-96D1-AEAF6E7D1A8B
P2860
The impact of TP53 mutations and TP53 deletions on survival varies between AML, ALL, MDS and CLL: an analysis of 3307 cases.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The impact of TP53 mutations a ...... LL: an analysis of 3307 cases.
@en
type
label
The impact of TP53 mutations a ...... LL: an analysis of 3307 cases.
@en
prefLabel
The impact of TP53 mutations a ...... LL: an analysis of 3307 cases.
@en
P2093
P2860
P356
P1433
P1476
The impact of TP53 mutations a ...... LL: an analysis of 3307 cases.
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2016.263
P577
2016-09-29T00:00:00Z
P6179
1018020024